资讯

Joie Armstrong asked her doctor about taking a GLP-1 medication to help her lose weight six times before she got a prescription, and then was denied coverage by her insurance company. Adrian, a ...
Lilly said it had taken many steps to address patient safety risks posed by the proliferation of unsafe or untested tirzepatide. The company said it is filing lawsuits, educating consumers and working ...
A new animal study presented reveals how two leading anti-obesity drugs, tirzepatide and semaglutide, uniquely influence the body’s energy use during and after treatment. Credit: Shutterstock ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Testing is the biggest expenditure in his tirzepatide-making process (he and other DIY-ers send their samples for testing in bulk for extra assurance and cost savings).
Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.
Despite promising adherence and persistence data, tirzepatide dose escalation was slower in the real-world than clinical trials in patients with obesity without T2D.
Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.
It contains tirzepatide, which is the active ingredient in the brand-name drug Mounjaro. If you cannot take Mounjaro for medical reasons, you may need compounded tirzepatide.
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1, receptor agonist, has shown promise in promoting weight loss and improving ...